|
WO2020239568A1
|
|
Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof
|
|
WO2018211080A1
|
|
(+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof
|
|
US10875829B1
|
|
Azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
|
|
WO2016185032A1
|
|
Novel azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission
|
|
MX2013012025A
|
|
Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission.
|
